Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -1578.40% is 2670% below its 5-year average of -56.99%, around the middle of its 5-year range (-12206.54%–11988.25%).
2760.88% below its 12-month average of -55.17%.
Reported quarterly profit margin; no daily interpolation. Q4 FY2026 (2026-06-30): -417.70%.
NET PROFIT MARGIN
-1578.40%
NET PROFIT MARGIN AVG TTM
-55.17%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
-56.99%
NET PROFIT MARGIN AVG 10Y
-109.49%
NET PROFIT MARGIN AVG 15Y
-91.01%
NET PROFIT MARGIN AVG 20Y
-44.96%
CURRENT VS TTM AVG
-2760.88%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
-2669.66%
CURRENT VS 10Y AVG
-1341.54%
CURRENT VS 15Y AVG
-1634.24%
CURRENT VS 20Y AVG
-3410.36%
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-606976.92%
vs the sector median at left
Neuphoria Therapeutics Inc.
Market Cap
$18.62M
Net Profit Margin
-1578.40%
TTM Avg
-55.17%
3Y Avg
0.00%
5Y Avg
-56.99%
Market Cap
$17.32M
Net Profit Margin
-33.08%
TTM Avg
-29.53%
3Y Avg
-30.32%
5Y Avg
-22.32%
Market Cap
$19.28M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$18.18M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$17.46M
Net Profit Margin
-6.55%
TTM Avg
-9.60%
3Y Avg
-12.37%
5Y Avg
-13.41%
Market Cap
$17.23M
Net Profit Margin
-10794.64%
TTM Avg
946.68%
3Y Avg
-6081.70%
5Y Avg
-5732.70%
Market Cap
$17.19M
Net Profit Margin
-755.13%
TTM Avg
-243.50%
3Y Avg
-516.28%
5Y Avg
-344.84%
Market Cap
$17.14M
Net Profit Margin
-63.54%
TTM Avg
-31.77%
3Y Avg
-305.26%
5Y Avg
2352.19%
Market Cap
$20.16M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | $18.62M | -1578.40% | -55.17% | 0.00% | -56.99% |
| Cosmos Health Inc. (COSM)vs › | $17.32M | -33.08% | -29.53% | -30.32% | -22.32% |
| Actuate Therapeutics Inc (ACTU)vs › | $19.28M | 0.00% | 0.00% | 0.00% | 0.00% |
| Estrella Immunopharma, Inc. (ESLA)vs › | $18.18M | 0.00% | 0.00% | 0.00% | 0.00% |
| P3 Health Partners Inc. (PIII)vs › | $17.46M | -6.55% | -9.60% | -12.37% | -13.41% |
| PAVmed Inc. (PAVM)vs › | $17.23M | -10794.64% | 946.68% | -6081.70% | -5732.70% |
| Lipocine Inc. (LPCN)vs › | $17.19M | -755.13% | -243.50% | -516.28% | -344.84% |
| Palatin Technologies, Inc. (PTN)vs › | $17.14M | -63.54% | -31.77% | -305.26% | 2352.19% |
| Quantum BioPharma Ltd. (QNTM)vs › | $20.16M | 0.00% | 0.00% | 0.00% | 0.00% |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | -706.23% | -81.41% | -315.86% | -1797.64% |
Operating Margin
-835.5%
Net Profit Margin
-1578.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -417.70% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 141.84% |
| 2025-03-31 | 75.08% |
| 2024-12-31 | -293.24% |
| 2024-09-30 | -8.01% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 11988.25% |
| 2023-03-31 | 11807.58% |
| 2022-12-31 | -12206.54% |
| 2022-09-30 | -12206.35% |
| 2022-06-30 | -147.91% |
| 2022-03-31 | -147.91% |
| 2021-12-31 | -7707.36% |
| 2021-09-30 | -7707.28% |
| 2021-06-30 | -2688.60% |
| 2021-03-31 | -2688.61% |
| 2020-12-31 | -2.10% |
| 2020-09-30 | -2.10% |
| 2020-06-30 | -32.52% |
| 2020-03-31 | -32.52% |
| 2019-12-31 | -392.93% |
| 2019-09-30 | -392.93% |
| 2019-06-30 | 5.17% |
| 2019-03-31 | 25.03% |
| 2018-12-31 | -367.98% |
| 2018-09-30 | -367.98% |
| 2018-06-30 | -344.55% |
| 2018-03-31 | -344.55% |
| 2017-12-31 | -123.41% |
| 2017-09-30 | -123.41% |
| 2017-06-30 | 14.80% |
| 2017-03-31 | 14.80% |
| 2016-12-31 | -135.88% |
| 2016-09-30 | -135.87% |
| 2016-06-30 | -76.50% |
| 2016-03-31 | -76.50% |
| 2015-12-31 | -94.92% |
| 2015-09-30 | -94.92% |
| 2015-06-30 | -144.47% |
| 2015-03-31 | -144.47% |
| 2014-12-31 | -77.50% |
| 2014-09-30 | -77.50% |
| 2014-06-30 | 45.92% |
| 2013-12-31 | 0.00% |
| 2013-06-30 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-06-30 | 0.00% |
| 2011-12-31 | 0.00% |
| 2011-06-30 | 0.00% |
| 2010-12-31 | 0.00% |
| 2010-06-30 | 0.00% |
| 2009-12-31 | 0.00% |
| 2009-06-30 | 0.00% |
| 2008-12-31 | 0.00% |
| 2008-06-30 | 0.00% |
| 2007-12-31 | 0.00% |
| 2007-06-30 | 0.00% |
| 2006-12-31 | 0.00% |
| 2006-06-30 | 0.00% |
| 2005-12-31 | 0.00% |
| 2005-06-30 | 0.00% |
| 2004-12-31 | 0.00% |
| 2004-06-30 | 0.00% |
| 2003-12-31 | 0.00% |
| 2003-06-30 | 0.00% |
| 2002-06-30 | 0.00% |
| 2001-06-30 | 0.00% |
